Identification of ST3GAL5 as a prognostic biomarker correlating with CD8+ T cell exhaustion in clear cell renal cell carcinoma
Aberrant sialylation is frequently observed in tumor development, but which sialyltransferases are involved in this event are not well known. Herein, we performed comprehensive analyses on six ST3GAL family members, the α-2,3 sialyltransferases, in clear cell renal cell carcinoma (ccRCC) from public...
Main Authors: | Jiakuan Liu, Meiqian Li, Jiajun Wu, Qi Qi, Yang Li, Simei Wang, Shengjie Liang, Yuqing Zhang, Zhitao Zhu, Ruimin Huang, Jun Yan, Rujian Zhu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-09-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.979605/full |
Similar Items
-
ST6GAL1 is associated with poor response to chemoradiation in rectal cancer
by: Mary Smithson, et al.
Published: (2024-05-01) -
Whole-cell tumor vaccines desialylated to uncover tumor antigenic Gal/GalNAc epitopes elicit anti-tumor immunity
by: Jianmei Huang, et al.
Published: (2022-10-01) -
Sialylation is involved in cell fate decision during development, reprogramming and cancer progression
by: Fenjie Li, et al.
Published: (2018-11-01) -
Generation of αGal-enhanced bifunctional tumor vaccine
by: Jian He, et al.
Published: (2022-07-01) -
Hyper α2,6‐Sialylation Promotes CD4+ T‐Cell Activation and Induces the Occurrence of Ulcerative Colitis
by: Qingjie Fan, et al.
Published: (2023-09-01)